Ilya Zubkov
Stock Analyst at Freedom Broker
(1.81)
# 4,378
Out of 5,178 analysts
20
Total ratings
35%
Success rate
-5.42%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Buy | $8 → $10 | $3.94 | +153.81% | 1 | Mar 12, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $100 → $105 | $55.55 | +89.02% | 2 | Mar 2, 2026 | |
| LGCY Legacy Education | Maintains: Buy | $13 → $15 | $12.95 | +11.97% | 1 | Feb 24, 2026 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $470 → $410 | $328.16 | +24.94% | 2 | Feb 17, 2026 | |
| ABBV AbbVie | Maintains: Buy | $245 → $260 | $211.12 | +23.15% | 3 | Feb 17, 2026 | |
| LLY Eli Lilly and Company | Upgrades: Buy | $1,050 → $1,200 | $897.00 | +33.78% | 3 | Feb 10, 2026 | |
| MRK Merck & Co. | Maintains: Hold | $90 → $110 | $118.93 | -7.51% | 1 | Feb 9, 2026 | |
| JNJ Johnson & Johnson | Maintains: Hold | $190 → $220 | $239.24 | -8.04% | 2 | Jan 27, 2026 | |
| BFLY Butterfly Network | Initiates: Buy | $5 | $4.15 | +20.48% | 1 | Dec 31, 2025 | |
| AMGN Amgen | Maintains: Hold | $330 → $360 | $353.16 | +1.94% | 1 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $475 → $560 | $468.55 | +19.52% | 1 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $38 | $37.96 | +0.11% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.63 | +242.21% | 1 | Sep 17, 2025 |
LifeMD
Mar 12, 2026
Maintains: Buy
Price Target: $8 → $10
Current: $3.94
Upside: +153.81%
BioMarin Pharmaceutical
Mar 2, 2026
Maintains: Buy
Price Target: $100 → $105
Current: $55.55
Upside: +89.02%
Legacy Education
Feb 24, 2026
Maintains: Buy
Price Target: $13 → $15
Current: $12.95
Upside: +11.97%
Alnylam Pharmaceuticals
Feb 17, 2026
Upgrades: Buy
Price Target: $470 → $410
Current: $328.16
Upside: +24.94%
AbbVie
Feb 17, 2026
Maintains: Buy
Price Target: $245 → $260
Current: $211.12
Upside: +23.15%
Eli Lilly and Company
Feb 10, 2026
Upgrades: Buy
Price Target: $1,050 → $1,200
Current: $897.00
Upside: +33.78%
Merck & Co.
Feb 9, 2026
Maintains: Hold
Price Target: $90 → $110
Current: $118.93
Upside: -7.51%
Johnson & Johnson
Jan 27, 2026
Maintains: Hold
Price Target: $190 → $220
Current: $239.24
Upside: -8.04%
Butterfly Network
Dec 31, 2025
Initiates: Buy
Price Target: $5
Current: $4.15
Upside: +20.48%
Amgen
Nov 12, 2025
Maintains: Hold
Price Target: $330 → $360
Current: $353.16
Upside: +1.94%
Oct 28, 2025
Maintains: Buy
Price Target: $475 → $560
Current: $468.55
Upside: +19.52%
Oct 17, 2025
Initiates: Buy
Price Target: $38
Current: $37.96
Upside: +0.11%
Sep 17, 2025
Initiates: Buy
Price Target: $9
Current: $2.63
Upside: +242.21%